A Trojan horse for thirsty tumours
Elie Dolgin • July 11, 2024
Joining a drug candidate to a protein that malignant cells naturally take up allowed one firm to come up with a potent anti-cancer therapy.
Read at Nature Outlook.
Circulating biomarkers are quickly becoming a crucial part of diagnosis and disease monitoring for physicians, researchers — and even some consumers.
Zebras and giraffes offer one another protection without food competition.